Publication | Closed Access

Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients

HypertensionAngiotensin IiCardiovascular DiseaseSodium HomeostasisMedicineAntihypertensive TherapyPhysiologyCardiovascular PharmacologyPharmacotherapySodium FactorsPharmacologyRenal PharmacologyBlood PressurePartial Competitive Agonist